跳转至内容
Merck
CN

379239

Sigma-Aldrich

三甲基铝 溶液

2.0 M in heptane

登录查看公司和协议定价

别名:
Aluminum trimethanide solution
线性分子式:
(CH3)3Al
CAS号:
分子量:
72.09
Beilstein:
3587197
MDL编号:
UNSPSC代码:
12352103
PubChem化学物质编号:
NACRES:
NA.22

形式

liquid

质量水平

浓度

2.0 M in heptane

密度

0.693 g/mL at 25 °C

SMILES字符串

C[Al](C)C

InChI

1S/3CH3.Al/h3*1H3;

InChI key

JLTRXTDYQLMHGR-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

Trimethylaluminum can be used in the synthesis of methylaluminoxane (MAO), a precatalyst for olefin polymerization. It is a precursor for the preparation of a wide range of organoaluminium such as dimethylaluminum chloride and bis(trimethylaluminum)-1,4-diazabicyclo[2.2.2]-octane (DABAL-Me3).

警示用语:

Danger

危险分类

Aquatic Acute 1 - Aquatic Chronic 1 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Pyr. Liq. 1 - Skin Corr. 1B - STOT SE 3 - Water-react 1

靶器官

Central nervous system

补充剂危害

WGK

WGK 2

闪点(°F)

closed cup

闪点(°C)

closed cup

个人防护装备

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Gasometric titration for dimethylaluminum chloride analysis.
Wang L, et al.
Journal of Pharmaceutical and Biomedical Analysis, 125, 110-113 (2016)
Remarkably Stable (Me3Al) 2? DABCO and Stereoselective Nickel?Catalyzed AlR3 (R= Me, Et) Additions to Aldehydes.
Biswas K, et al.
Angewandte Chemie (International Edition in English), 44(15), 2232-2234 (2005)
Methylaluminoxane: synthesis, characterization and catalysis of ethylene polymerization.
Reddy S S, et al.
Polymer Bull., 36(2), 165-171 (1996)
Mahtab Farzin et al.
Pathology, 47(4), 302-307 (2015-05-06)
BRCA1-associated protein 1 (BAP1) is a tumour suppressor gene frequently inactivated in mesothelioma, rarely also in association with germline mutation. BAP1 mutations have been associated with improved prognosis and distinct clinicopathological features. We sought to determine the clinicopathological significance of
J L L Robinson et al.
Oncogene, 33(50), 5666-5674 (2013-12-03)
Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门